Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
about
Pathological bases for a robust application of cancer molecular classificationFluorescence in situ hybridization in surgical pathology: principles and applications.Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis.Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studiesNewly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleRenal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.Doing more with less: New markers for sarcoma diagnosis and their applicability to cytology specimens.Juxtaglomerular cell tumor: Clinical and immunohistochemical features.Frequent expression of human leukocyte antigen class I and the status of intratumoral immune cells in alveolar soft part sarcoma.Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.Alveolar soft part sarcoma occurring in the penis of a 3-year-old boy: A rare case report.TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.Long non-coding RNA ZNF674-1 acts as a cancer suppressor in nasopharyngeal carcinoma.
P2860
Q28082201-9B51AEAE-1614-4A7F-9DE6-ABE627983517Q33593910-312F821C-E8CB-40F9-AEC0-9BF0E080539AQ35019504-52EA03F1-BFBE-4A8D-80AA-4F7164BA1981Q36061395-54B990E9-4213-413E-AACC-85BF52FDC837Q36073126-15D71669-0906-47E7-B5E0-4410B4CE0391Q36151526-144DEC8A-220D-48CA-A431-EEEE44ABADF4Q36205571-537DED4C-1B83-4BA9-9E09-995866BDB845Q37170478-336DD39B-FDC6-41B4-B6BA-F69E5339EEF8Q38238574-4B9BDF4D-A25E-464D-B01B-BBF695C86BA2Q38378763-53C9CEFF-FD5B-4738-B07A-E927337F266CQ38388597-2F4E7BDE-02D9-431A-AE22-A2A0621D3964Q38546367-222FDA73-B0B5-4100-8F34-9F59A58AA51FQ38700995-97E4A9CF-CAF3-411C-81A6-2705FF53812FQ38895043-3F23F2E6-2699-4825-B7B8-E3D8F2F51A6FQ42290628-81DD7939-21C4-49F8-AC88-C8FF7E7EEBECQ42773286-3BFF752E-440E-468F-B8C8-8D20EF9C0976Q46611738-E3A664A6-FDB4-4230-A4AA-E94D72724986Q47137670-819C91E0-096A-4422-B065-884A364FFB49Q52779937-90C83216-5173-49F1-98E9-9FC88ED31408Q55279099-5957E38E-642D-4740-9C05-071772E8A429
P2860
Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@ast
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@en
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@nl
type
label
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@ast
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@en
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@nl
prefLabel
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@ast
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@en
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@nl
P2093
P2860
P1433
P1476
Molecular cytogenetic analysis ...... ical experience with 75 cases.
@en
P2093
Andre M Oliveira
Anne E Wiktor
Kathryn E Pearce
Patricia T Greipp
Xiaoke Wang
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.83
P577
2013-07-05T00:00:00Z
P5875
P6179
1006893839